✨ 4 results found - Searched 21206 records in 3ms.
Disertasi
Potensi Ekstrak Tertarget Lunasin (ET-Lun) dari Biji Kedelai pada Penghambatan Karsinogenesis Kanker Payudara (Studi in silico dan in vivo).
2022 | BY Ani Retno Prijanti - Erni Hernawati Purwaningsih - Kusmardi - Andon Hestiantoro - Numlil Khaira Rusdi- Antimammary Tumor Effect of Soybean Extract with Targeted Lunasin (ET-Lun) – In silico and in vivo studies.
- Nomor Panggil D22001fk
Tesis
Profil dan Angka Tahan Hidup 1 tahun Kanker Paru Bukan Sel Kecil (KPKBSK) Jenis Adenokarsinoma Paru dengan Mutasi Epidermal Growth Factor Receptor (EGFR) Exon 20 T790M Primer di RSUP Persahabatan
2018 | BY Hapsari Retno Dewanti - Sita Laksmi Andarini - Jamal Zaini- The Characteristics and One Year Survival of Lung Adenocarcinoma Patients with Primary Exon 20 T790M Epidermal Growth Factor Receptor Mutation Treated at Persahabatan Hospital Jakarta, Indonesia.
- Nomor Panggil T18468fk
Tesis
Profil Efikasi dan Toksisitas Terapi Target Baru Golongan Epidermal Factor Receptor-Tyrosine Kinase Inhibitor (EGFRTKi)Pada Pasien Kanker Paru Karsinoma Bukan Sel Kecil Non Skuamosa Dengan Mutasi EGFR Positif Dibandingkan Dengan Kemoradioterapi Pada EGFR Wild Type
2014 | BY Sita Laksmi Andarini - Wiendo Syah Putra Yahya - Achmad Hudoyo - Ahmad Utomo- Profile of Efficacy and Toxicity The New Targeted Therapy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKi) in Non Small Cell Lung Cancer Non-Squamous With Mutated EGFR Compared With Chemoradiotherapy In Wild Type
- Nomor Panggil T14533fk
Tesis
Evaluasi terapi kombinasi radiasi dan nimotuzumab (h-R3 MAb) dalam pengobatan kanker leher rahim stadium III
2012 | BY Arie Munandar - Soehartati Gondhowiardjo- Evaluation of Radiotherapy combined with Nimotuzumab (h-R3 MAb) in the treatment of stage III cervical cancer.
- Nomor Panggil T12402fk